An Unbiased View of Molnupiravir
Patients that are currently obtaining medications which can be powerful inducers or inhibitors of CYP3A4 will not be eligible. Strong inducers or inhibitors of CYP3A4 needs to be avoided from fourteen days previous to enrollment to the top in the study.A.G.H. has received investigate funding from Bayer AG and is also a founder and shareholder of AM